Medindia
Medindia LOGIN REGISTER
Advertisement

ev3 Inc. Appoints John L. Miclot to Board of Directors

Thursday, December 4, 2008 General News
Advertisement
PLYMOUTH, Minn., Dec. 3 ev3 Inc. (Nasdaq: EVVV),a global endovascular device company, today announced the appointment of JohnL. Miclot to its Board of Directors effective immediately.
Advertisement

Mr. Miclot is currently the president and chief executive officer of CCSMedical, a privately held nationwide provider of various home care productsfor chronic diseases such as diabetes, wound care, urology and respiratorydisorders. Prior to joining CCS Medical, Mr. Miclot served as chief executiveofficer of Philips Home Healthcare Solutions from March 2008 until November2008 following the acquisition of Respironics, Inc. by Philips. From December2003 to March 2008, Miclot served as president and chief executive officer ofRespironics, Inc. Prior to that, Mr. Miclot served in various positions atRespironics, Inc. from 1998 to 2003, including chief strategic officer andpresident of the Homecare Division. Mr. Miclot joined Respironics in 1998when it acquired Healthdyne Technologies where he had served as senior vicepresident, sales and marketing from 1995 to 1998.
Advertisement

Mr. Miclot currently serves on the board of directors of Wright MedicalGroup and several private companies including CCS Medical.

"We are delighted to have someone with John's proven leadership skills andextensive operational expertise join our board," said Robert Palmisano,president and chief executive officer of ev3. "John's insight and experiencewill be of great value as we work towards building the premier endovascularcompany and preferred physician partner for identifying and treatingperipheral vascular and neurovascular disease."

About ev3 Inc.

Since its founding in 2000, ev3 has been dedicated to developinginnovative, breakthrough and clinically proven technologies and solutions forthe treatment of peripheral vascular and neurovascular diseases. ev3'sproducts are used by endovascular specialists to treat a wide range ofperipheral vascular and neurovascular diseases and disorders. The companyoffers a comprehensive portfolio of treatment options, including the primaryinterventional technologies used today -- peripheral angioplasty balloons,stents, plaque excision systems, embolic protection devices, liquid embolics,embolization coils, thrombectomy catheters and occlusion balloons. Moreinformation about the company and its products can be found athttp://www.ev3.net.

ev3 and the ev3 logo are trademarks of ev3 Inc., registered in the U.S.and other countries.

SOURCE ev3 Inc.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close